Compare your quality, regulatory readiness, and operational performance against hundreds of your life sciences peers across MedTech, diagnostics, pharma, and biotech.

What’s Inside the Report:

• How QA, RA, and manufacturing teams compare on FDA-QMSR preparedness, quality improvement challenges, post-market surveillance readiness, and top operational risks.
• The most significant quality and compliance gaps leaders are prioritizing in 2026—and the practices that distinguish high-performing organizations.
• Where the industry is accelerating, where it’s falling behind, and how leading teams are preparing for the next wave of regulatory and operational demands.

Read the full report to see where your organization stands—and what’s shaping life sciences quality and compliance in 2026.